 Labrador Diagnostics alleges that BioFire’s FilmArray technology which was first introduced to the market in the early 1990s and has since been developed into a variety of FilmArray technologies infringes on its patents for "systems and methods of sample processing and fluid control in a fluidic system" and "Point-of-Care Fluidic Systems and Uses Thereof" filed by Theranos in 2006.On March 3, 2020, six days before the lawsuit was filed, the Wall Street Journal published an article identifying BioFire and the fact it was working on two diagnostic tests for COVID-19, the discovery of this prompted media backlash against Fortress and SoftBank.In response to the backlash, Fortress issued a statement claiming that when its subsidiary filed the lawsuit against BioFire it had no idea BioFire was developing COVID-19 testing kits.